Dr Reddys and Fujifilm call off JV for generic drugs in Japan

Pharma stocks like Dr Reddys Labs, Divis Labs, Biocon, Sun Pharma and Lupin will be getting astrological support, says Satish Gupta of Astrostocktips.

GV Prasad, Forbes India | Posted on Jun 17, 2013 at 11:51am IST New Delhi: When I came back to India after graduation in the US, I knew I wanted to start a business but what that would be I didn't know. I joined the family business for a while and then set up ...

The main gainers on the Sensex at this hour include M&M, Bharti Airtel, Hero Moto, Hindalco, Infosys and Dr Reddy's email this article Subject line: Your Email: Send me a copy: Recipients Id: Type address separated by commas Enter the characters shown in the ...

The former Health Minister Dr DL Ravindranath Reddy said on Thursday that he would take to task Chief Minister Kiran Kumar Reddy in the coming Assembly session. He said that he would go round the villages in his own constituency after the Assembly ...

Sun, Lupin and Dr Reddy’s to lead here, with domestic formulations expected to rebound after Sept quarter. After posting a strong 20-plus per cent growth in the March quarter, top Indian pharmaceutical companies are expected to show similar growth in 2013-14. While the momentum is likely to come from the US market, the revival in domestic business should also help overall revenue growth.Manoj Garg and Perin Ali of Edelweiss Securities say revenue growth should sustain at double digits in ...

Chief Minister N Kiran Kumar Reddy on Monday appointed a nine-member Cabinet Sub-Committee on Bangaru Thalli scheme. The Sub-Committee members are - Sunitha Laxma Reddy, Dr J Geetha Reddy, DK Aruna, Galla Aruna Kumari, Anam Ramanarayana Reddy, ...

Sudarshan Sukhani of s2analytics.com says he is upbeat on Dr Reddys Labs, Sun Pharmaceutical and Cipla.

Vishal Malkan of malkansview.com advised buying Dr Reddys Labs and TCS. Meanwhile, Gaurav Ratnaparkhi of Sharekhan recommended selling Reliance Power and Future Retail.

reserved. IRIS Business